Vivos (RDGL) EPS (Basic) Growth (5y) (2015 - 2025)
Vivos (RDGL) EPS (Basic) Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.93% |
| Sep 30, 2025 | -14.06% |
| Jun 30, 2025 | -9.16% |
| Mar 31, 2025 | 0.45% |
| Dec 31, 2024 | 2.79% |
| Sep 30, 2024 | 12.13% |
| Jun 30, 2024 | -1.54% |
| Mar 31, 2024 | -51.82% |
| Dec 31, 2023 | -15.43% |
| Sep 30, 2023 | 51.85% |
| Jun 30, 2023 | 48.56% |
| Mar 31, 2023 | 44.95% |
| Dec 31, 2022 | 48.28% |
| Sep 30, 2022 | 53.47% |
| Jun 30, 2022 | 41.24% |
| Mar 31, 2022 | 28.58% |
| Dec 31, 2021 | -15.33% |
| Sep 30, 2021 | 40.14% |
| Jun 30, 2021 | -22.06% |
| Mar 31, 2021 | 19.90% |